Investor · Delanson, NY

Chris Garabedian

Open Chris in the network graph →

Filings

14

SEC Form D

Connections

70

co-filers

Capital

$130.3M

across filings

Active

May 2016

to Jun 2024

Most-connected co-filers (70)

Chris J. Garabedian · Grove City, OH9 shared Frederick Callori · Philadelphia, PA9 shared Valerie M. Bauer Gore · Columbus, OH2 shared Tomas Kiselak · West Conshohocken, PA2 shared Debora M. Covell · Wyomissing, PA2 shared James C. Waldinger · New York, NY2 shared Vijay W. Palkar · New York, NY2 shared Jonathan E. Violin · Waltham, MA2 shared David H. Treitel · Boca Raton, FL2 shared Stephen M. Wagman · Boca Raton, FL2 shared Jonathan Poma · Columbus, OH2 shared Peter Harwin · West Conshohocken, PA2 shared Louise W. Smith · Richmond, VA2 shared William D. Schwieterman · South San Francisco, CA1 shared Amber A. Tencic · STAMFORD, CT1 shared Francis Chen · Newton, MA1 shared Noah Welch · Pompano Beach, FL1 shared John Mcmichael · Delanson, NY1 shared Jeffrey S. Muir · Atlanta, GA1 shared Sapna S. Srivastava · Baltimore, MD1 shared Lu Huang · London, United Kingdom1 shared (Investment Manager) Land & Buildings Investment Management LLC · Stamford, CT1 shared Jeffrey A. Eckmann · Delanson, NY1 shared Jordan J. Green · Baltimore, MD1 shared

Recent filings (14)

Marea Therapeutics, Inc.Jun 2024 · 23 co-filers$160.4M AsclepiX Therapeutics, Inc.Apr 2024 · 22 co-filers$12.5M PolyCore Therapeutics, Inc.Mar 2022 · 9 co-filers$4.7M Stream Biomedical, Inc.Jan 2022 · 7 co-filers$21.5M Juno Diagnostics, Inc.May 2021 · 7 co-filers$29.8M NephroDI Therapeutics, Inc.Feb 2021 · 9 co-filers$1.6M NephroDI Therapeutics, Inc.Feb 2021 · 9 co-filers$1.6M Quellis Biosciences, Inc.Dec 2020 · 7 co-filers$1.0M Quellis Biosciences, Inc.Dec 2020 · 7 co-filers$1.0M Quellis Biosciences, Inc.Aug 2020 · 7 co-filers$18.5M Quellis Biosciences, Inc.Aug 2020 · 7 co-filers$18.5M CereVasc, Inc.Jun 2020 · 13 co-filers$32.5M Landos Biopharma, Inc.Aug 2019 · 1 co-filer$60.3M Vyome Therapeutics Inc.Jan 2019 · 17 co-filers$11.3M Quellis Biosciences, Inc.Dec 2018 · 9 co-filers$18.5M Quellis Biosciences, Inc.Dec 2018 · 9 co-filers$18.5M Quellis Biosciences, Inc.Jun 2018 · 9 co-filers Resolys Bio, Inc.May 2016 · 9 co-filers$7.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Chris in the interactive graph →